Copy For Citation
Erzin G., Topcuoglu C., Bayram S., Karadag H., ÖZKAYA G., Turhan T., ...More
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, vol.29, no.4, pp.394-398, 2019 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
29
Issue:
4
-
Publication Date:
2019
-
Doi Number:
10.1080/24750573.2019.1589175
-
Journal Name:
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.394-398
-
Keywords:
Schizophrenia, neuroendocrine, peripheral markers, DORSOLATERAL PREFRONTAL CORTEX, NEGATIVE SYNDROME SCALE, INSULIN-SECRETION, GENE-EXPRESSION, NEURONS, RELIABILITY, VALIDITY, DEFICITS, GABA
-
Bursa Uludag University Affiliated:
Yes
Abstract
OBJECTIVE: Schizophrenia is a neurodegenerative and neurodevelopmental disorder. For this reason, it is important to determine the level of markers that are neuroprotective and have been altered in other neurodegenerative diseases in inspecting the etiology of schizophrenia. Secretagogin (SCGN), is a member of Calcium (Ca) binding proteins and thought to have a neuroprotective effect. In this study, we aimed to compare the level of secretagogin (SCGN) between age and gender-matched schizophrenia and control group.